Authors: Imdad Ali Ansari, Azizullah Jalbani, Aftab Hussain Shah, Kouro Mal Gurbakhshani, Ghulam Akbar Solangi, Abrar Shaikh
Abstract
Most patients due to cirrhosis develop esophageal varices due to portal hypertension and
present with acute and often fatal gastrointestinal (G.I) bleeding. The purpose of this study
was to establish Octreotide or Terlipressin, as the first line of pharmacological therapies
in controlling acute variceal bleeding, particularly where the facilities for ligation and banding are not available OBJECTIVES:To compare the efficacy of Terlipressin and Octreotide in initial management of acute variceal bleeding.To document the safety of Terlipressin and Octreotide in initial management of acute variceal bleeding. STUDY DESIGN:Single blinded, comparative study. SETTING:Medical-II wards, Chandka Medical Collage Hospital (CMCH) Larkana. DURATION WITH DATES:One year from March 2007 to March 2008. SUBJECTS AND METHODS:57 patients, who reported with acute upper G.I bleeding, were included and divided alternatively in two groups. Group A (22) patients were given injection Terlipressin where as Group B (35) patients received injection Octreotide. Treatment was continued at least for 03 days in both groups. RESULTS:Bleeding was controlled in 21 (95.4%) patients of Group A and 26 (74.2%)
patients of Group B (P=0.392). Re-bleeding was seen in 01 (2.85%) patient of Group
B. Failure of therapy was noted in 09 (25.71%) patients of Group B (P=0.063). Mortality
was also higher in Group B (28.5%) (P=0.04). Both therapies had no side effects.
CONCLUSION:Both vasoactive agents were effective and safe but Terlipressin had slight
edge over Octreotide due to its simple intravenous dosage and rapid haemostasis.
Keywords: Octreotide, Terlipressin, Variceal bleeding, Endoscopic Ligation, Endoscopic Banding, Upper G.I bleeding, Vasoactive agents, Haemostasis.
